David Natan

David Natan is recorded as Board Member at Indaptus Therapeutics, Inc. (INDP) since January 1, 2026, Board Member at Quantum Cyber N.V. (QUCY) since January 1, 2026 and Board Member at Vivakor, Inc. (VIVK) since December 15, 2022. The newest filing on record that lists David Natan as Board Member at Indaptus Therapeutics, Inc. (INDP) is dated July 16, 2026. The newest filing on record that lists David Natan as Board Member at Quantum Cyber N.V. (QUCY) is dated June 1, 2026. FiEE, Inc. reported in an 8-K filed October 2, 2026 that David Natan resigned as director, effective September 30, 2026. FiEE, Inc. reported in an 8-K filed September 11, 2026 that David Natan resigned as a member of the Board of Directors (the "Board") of FiEE, Inc. (the "Company"), and the Chair of the Audit Committee of the Boar, effective September 30, 2026. Quantum Cyber N.V. reported in an 8-K filed April 28, 2026 that David Natan was appointed director, effective April 22, 2026. Equibles holds 11 filed executive changes naming David Natan; each is listed under recent activity with its source filing. FiEE, Inc. is classified in the Communication Equipment industry within the Technology sector. Indaptus Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at FiEE, Inc. includes Joseph L. Wytanis (CEO), Li Wai Chung (CEO), Mehul Patel (CEO and Board Member) and 7 others.